Therapeutics: ADP-ribosylation factor 6 (ARF6); G protein q polypeptide (GNAQ; G-ALPHA-q)

Cancer

INDICATION: Melanoma

Cell culture and mouse studies suggest inhibiting ARF6 could help treat GNAQ-mutant uveal

Read the full 148 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE